SEATTLE, July 05, 2021, (MEDGADGET) — Positron emission tomography (PET) is an imaging technique that is used to examine diseases and metabolic activities of tissues and organs inside the body with the use of radiotracer that is administered intravenously. In this technique, scan uses a special dye that has a radioactive tracers, and is administered as an intravenous injection labelled with oxygen15, nitrogen13 and fluorine18 (C-11, Fl-18, O-15 or N-13). These tracers are injected in the peripheral vein that move through blood circulation and helps to identify the blocked areas of peripheral veins precisely. Generally, this scan takes around 40 minutes to complete and it also measures the rate of glucose in the body. Moreover, this scan is a painless procedure. PET procedures provides information about the organs and tissues, shape, size and the position. PET is widely used by oncologists for diagnoses of various types of cancer and cardiologists, in order to diagnose cardiovascular diseases. Clinical use of PET is that it can distinguish between the non-malignant tumors and malignant tumors. PET is also used to map brain function and diagnosis of condition of diseases such as Alzheimer’s disease.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/693
Rising number of chronic disease cases such as cancer and increasing prevalence of Alzheimer’s disease (AD), around the globe are expected to boost growth of the positron emission tomography (PET) market over the forecast period
North America and Asia Pacific are expected to dominate the positron emission tomography market over the forecast period, owing to factors such as rising prevalence of cancer and Alzheimer’s disease. For instance, according to the World Health Organization (WHO), around 8.8 million deaths occurred due to cancer in 2015. Furthermore, WHO launched global action plan for the prevention and control for cancer and other diseases in 2013 that aims to reduce around 25% of early stages of mortality from cancer by 2025. Moreover, according to the National Cancer Institute (NCI) in 2016, around 1,685,210 cases of cancer were diagnosed in the U.S. mainly due to the factors such as excess consumption of alcohol and smoking, which accounts for high proportion of cancer patients in the U.S. These factors are expected to fuel growth of the positron emission tomography market over the forecast period.
PET techniques are performed, in order to evaluate the progress of the treatment of diseases such as chronic diseases, hence rise in prevalence of diseases is expected to increase demand for PET over the forecast period. For instance, according to the WHO, in 2017, number of people living with dementia worldwide is around 47 million and is expected to increase to around 75 million by 2030, and the number of cases is expected to triple by 2050. Moreover, according to the Alzheimer’s Australia, in 2017, over 413,106 Australia population are living with dementia. Furthermore, among these, female population were more likely to suffer, which accounted for around 228,238 (55%) are female and 184,868 (45%) were male and the total number is expected to reach around 536,164 by 2025. Furthermore, dementia is the second leading cause of death in Australians, contributing to 5.4% of deaths in males and 10.6% in females every year. Thus increase in number of such diseases are expected to drive growth of the positron emission tomography market over the forecast period.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/positron-emission-tomography-scanners-market-3062
Key players operating in the market include Toshiba Corporation, Koninklijke Philips N.V., Siemens AG, Hitachi, Ltd., Positron Corporation, Mediso Ltd., Radiology Oncology Systems, Inc., Yangzhou Kindsway Biotech Co. Ltd., Positron Corporation, Segami Corporation, Spectrum Dynamics Ltd., Naviscan, Inc. and MedX Holdings Inc., IBA- Ion Beam Applicattions, and Modus Medical Devices Inc.
Key Developments –
- In February 2019, Koninklijke Philips N.V. launched Incisive CT at 2019 European Congress of Radiology for offering advanced solutions to the researchers, in order to meet their clinical and operational goals
- In November 2018, Koninklijke Philips N.V. announced to open new center of excellence and headquarters for research and development of its computed tomography and advanced molecular imaging (CT/AMI) business in Cleveland, U.S. in the first quarter of 2019
- In 2019, Government of British Columbia (B.C.) launched new Gordon Heys Family PET/CT (positron emission tomography/computed tomography) scanner suite in the B.C. Cancer Centre in Victoria
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/693
Positron Emission Tomography Market Taxonomy
Positron Emission Tomography Market by Product Type:
- Full Ring PET Scanners
- Partial Ring PET Scanners
Positron Emission Tomography Market by Application:
Positron Emission Tomography Market by End User:
- Others (Imaging Centers and Academic and Research Centers)
Positron Emission Tomography Market by Region:
- North America
- Latin America
- Asia Pacific
- Middle East
Table of Content
Global Positron Emission Tomography (PET) Scanners Market Research Report
Section 1: Global Positron Emission Tomography (PET) Scanners Industry Overview
Section 2: Global Economic Impact on Positron Emission Tomography (PET) Scanners Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Positron Emission Tomography (PET) Scanners Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Positron Emission Tomography (PET) Scanners Market Forecast
Other Related News:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027